![]() |
市場調査レポート
商品コード
1715741
動物用寄生虫駆除剤市場:タイプ別、動物タイプ別、適用形態別、寄生虫タイプ別、流通チャネル別、エンドユーザー別-2025-2030年世界予測Veterinary Parasiticides Market by Type, Animal Type, Mode Of Application, Parasite Type, Distribution Channel, End-User - Global Forecast 2025-2030 |
||||||
カスタマイズ可能
適宜更新あり
|
動物用寄生虫駆除剤市場:タイプ別、動物タイプ別、適用形態別、寄生虫タイプ別、流通チャネル別、エンドユーザー別-2025-2030年世界予測 |
出版日: 2025年04月01日
発行: 360iResearch
ページ情報: 英文 180 Pages
納期: 即日から翌営業日
|
動物用寄生虫駆除剤市場は、2024年に82億1,000万米ドルと評価され、2025年には88億3,000万米ドル、CAGR 7.78%で成長し、2030年には128億7,000万米ドルに達すると予測されています。
主な市場の統計 | |
---|---|
基準年 2024 | 82億1,000万米ドル |
推定年 2025 | 88億3,000万米ドル |
予測年 2030 | 128億7,000万米ドル |
CAGR(%) | 7.78% |
動物用寄生虫駆除剤市場は、進化する疾病パターン、薬剤処方の革新、動物の健康に対する意識の高まりの結果、大きな変革期を迎えています。競争の激しい今日の環境では、コンパニオンアニマルと家畜の双方にとって、寄生虫を効果的に駆除することが最も重要です。このサマリーでは、市場の現状を概説するとともに、市場の進化を促す要因について明らかにします。
現代の動物病院では、従来の寄生虫と新たな寄生虫の両方の課題に対処するため、高度な寄生虫駆除ソリューションを採用するケースが増えています。業界の成長に伴い、専門家は従来の治療と斬新なアプローチのバランスを取ることが求められています。規制の枠組みが進み、動物福祉基準が強化されたことで、より安全で効率的な薬剤の開発に弾みがついています。一方、動物の健康管理における技術の統合は、診断ツールの改良とより優れた送達メカニズムにつながっています。
このような開発と研究開発および持続可能性への強い関心が相まって、市場力学は再構築され、利害関係者は複雑な寄生虫感染症に対処するための能力を以前よりも向上させています。今後を展望すると、このような変化の環境は、先進的な寄生虫治療薬の可能性を最大限に活用する治療とデリバリーにおける技術革新の課題であると同時に、大きなチャンスでもあります。
動物用寄生虫駆除剤市場の変革
動物用寄生虫駆除剤の情勢は、急速な技術革新、進化する顧客需要、規制状況の影響を受け、大きく変化しています。市場参入企業は現在、寄生虫抵抗性の出現と動物飼育者層の変化という2つの課題に対応するため、戦略を再構築しています。薬理学の高度な研究開発により、有効性の向上だけでなく安全性プロファイルも改善された製剤が開発され、より厳格なコンプライアンス基準に適合するようになりました。
同時に、寄生虫感染症対策において、個別化された治療計画やより効果的な資源の活用を重視するプレシジョンメディシン(精密医療)へのシフトも顕著になっています。このパラダイムシフトにより、高品質の寄生虫駆除剤と補完的な健康製品や診断技術を組み合わせた、統合的な健康管理ソリューションの新時代が促進されつつあります。業界では、流通の合理化と顧客エンゲージメントの強化のため、デジタル・プラットフォームと人工知能への投資が進んでおり、革新的な治療法の迅速な導入への道が開かれつつあります。
さらに、世界市場では、競争力のあるイノベーションを促進しながらも、最高の安全基準を維持することを目的とした先進的な規制政策の影響が見られるようになっています。意思決定者がビジネスモデルを再調整する中で、共同研究イニシアチブを受け入れ、技術革新と持続可能な成長を一致させるパートナーシップを模索しています。このようなダイナミックな環境は競争を促進するだけでなく、継続的な市場拡大や治療成績の向上への勢いを後押ししています。
市場力学を牽引する主なセグメンテーション洞察
動物用寄生虫駆除剤市場は複雑にセグメント化されており、市場力学の原動力となる消費者ニーズと治療用途を多面的に理解することができます。製品タイプ別では、外部寄生虫駆除剤、内部寄生虫駆除剤、内部寄生虫駆除剤に分類されます。各製品は、寄生虫特有の課題に対応し、寄生虫の特定の行動に対応するよう処方されています。
もうひとつの重要な側面は、コンパニオンアニマルと家畜を区別する、動物の種類に基づくセグメンテーションです。コンパニオンアニマルには鳥類、猫、犬、爬虫類などが含まれ、家畜用とは異なる特殊な製剤が必要とされることが多いです。後者は牛、家禽、ヒツジ、ヤギ、豚で構成され、通常、大規模な畜産で遭遇する多様な寄生虫課題に効果的に対処できる幅広いスペクトラムのアプローチが求められます。
さらに、治療法を注射剤、経口剤、局所剤に分類し、適用形態に基づいてセグメンテーションを行う。この分類は、蔓延の重症度や獣医開業医の投与能力に応じたオーダーメイドのソリューションの必要性を反映しています。さらに、寄生虫の種類(条虫類、外部寄生虫、線虫類、振戦虫類など)に着目した区分もあり、これにより的を絞った治療戦略が可能になります。
市場流通も重要な役割を担っており、製品の入手しやすさや顧客行動を形成するオフライン小売とオンライン小売にチャネルが分かれています。最後に、エンドユーザーに基づくセグメンテーションは、動物農場、家庭のペットオーナー、動物病院をカバーし、動物農場はさらに酪農場、養鶏場、養豚場に分けられ、異なる顧客層の複雑な購買行動と多様なニーズを反映しています。これらのセグメンテーションは、市場需要の包括的なビューを提供し、技術革新と特化した製品開発の機会を明らかにします。
The Veterinary Parasiticides Market was valued at USD 8.21 billion in 2024 and is projected to grow to USD 8.83 billion in 2025, with a CAGR of 7.78%, reaching USD 12.87 billion by 2030.
KEY MARKET STATISTICS | |
---|---|
Base Year [2024] | USD 8.21 billion |
Estimated Year [2025] | USD 8.83 billion |
Forecast Year [2030] | USD 12.87 billion |
CAGR (%) | 7.78% |
The veterinary parasiticides market is undergoing a profound transformation as a result of evolving disease patterns, innovations in drug formulations, and rising awareness about animal health. In today's highly competitive environment, the need for effective parasitic control is paramount for both companion animals and livestock. This summary outlines the current state of the market while shedding light on the factors that are driving its evolution.
Modern veterinary practices have increasingly adopted advanced parasiticide solutions to address both conventional and emerging parasitic challenges. As the industry grows, professionals are required to balance traditional treatments with novel approaches. Progressive regulatory frameworks and heightened animal welfare standards have provided impetus for the development of safer, more efficient agents. Meanwhile, the integration of technology within animal health management has led to improved diagnostic tools and better delivery mechanisms.
These developments, coupled with a strong focus on research and sustainability, have reshaped market dynamics, ensuring that stakeholders are better equipped than ever before to tackle complex parasitic infestations. Looking ahead, this environment of change presents both challenges and significant opportunities for innovation in treatment and delivery that harness the full potential of advanced parasiticide therapies.
Transformative Shifts in the Parasiticides Market Landscape
The landscape of veterinary parasiticides has experienced transformative shifts driven by rapid innovation, evolving customer demands, and regulatory influences. Market participants are now reimagining their strategies to meet the dual challenges of emerging parasitic resistance and shifting demographics of animal ownership. Advanced research in pharmacology has facilitated the development of formulations that not only enhance efficacy but also improve safety profiles, thereby aligning with stricter compliance standards.
Concurrently, there has been a notable shift towards precision medicine in animal health, which emphasizes personalized treatment plans and a more effective use of resources in combating parasitic infestations. This paradigm shift is fostering a new era of integrated health management solutions that combine high-quality parasiticides with complementary health products and diagnostic technologies. The industry is increasingly investing in digital platforms and artificial intelligence to streamline distribution and enhance customer engagement, paving the way for quicker adoption of innovative therapies.
In addition, global markets are witnessing the influence of progressive regulatory policies which are intended to maintain the highest safety standards while promoting competitive innovation. As decision-makers recalibrate their business models, they are embracing collaborative research initiatives and seeking partnerships that align technological innovation with sustainable growth. This dynamic environment not only fuels competition but also fuels the momentum for continuous market expansion and enhanced therapeutic outcomes.
Key Segmentation Insights Driving Market Dynamics
The veterinary parasiticides market is intricately segmented, offering a multifaceted understanding of consumer needs and therapeutic applications that drive market dynamics. One dimension of the market is studied based on type, where products are categorized as ectoparasiticides, endectocides, and endoparasiticides. Each subset addresses unique parasitic challenges and is formulated to cater to specific parasitic behaviors.
Another important dimension involves segmentation based on animal type, which distinguishes between companion animals and livestock. Companion animals, which include birds, cats, dogs, and reptiles, require specialized formulations that are often different from those used in livestock. The latter, comprising cattle, poultry, sheep and goats, and swine, typically demands a broad-spectrum approach that can effectively address the diverse parasitic challenges encountered in larger scale animal husbandry.
Further segmentation is conducted on the basis of mode of application, delineating treatments into injectable, oral, and topical administrations. This categorization reflects the need for tailor-made solutions depending on the severity of infestation and the administration capabilities of veterinary practitioners. In addition, another segmentation focuses on the type of parasite addressed, including cestodes, ectoparasites, nematodes, and trematodes, which enables targeted therapeutic strategies.
Market distribution also plays a critical role, with channels divided into offline and online retail that shape product accessibility and customer behavior. Finally, segmentation based on the end-user covers animal farms, household pet owners, and veterinary hospitals, wherein animal farms are further dissected into dairy, poultry, and swine farms, reflecting the complex purchasing behaviors and diverse needs of different customer segments. Together, these segmentation insights offer a comprehensive view of market demand and highlight opportunities for innovation and specialized product development.
Based on Type, market is studied across Ectoparasiticides, Endectocides, and Endoparasiticides.
Based on Animal Type, market is studied across Companion Animals and Livestock Animals. The Companion Animals is further studied across Birds, Cats, Dogs, and Reptiles. The Livestock Animals is further studied across Cattle, Poultry, Sheep & Goats, and Swine.
Based on Mode Of Application, market is studied across Injectable Administration, Oral Administration, and Topical Administration.
Based on Parasite Type, market is studied across Cestodes, Ectoparasites, Nemotodes, and Trematodes.
Based on Distribution Channel, market is studied across Offline Retail and Online Retail.
Based on End-User, market is studied across Animal Farms, Household Pet Owners, and Veterinary Hospitals. The Animal Farms is further studied across Dairy Farms, Poultry Farms, and Swine Farms.
Regional Market Trends and Strategic Insights
A regional analysis of the veterinary parasiticides market reveals distinctive trends and strategic insights that underscore the diversity of demand across different geographies. In the Americas, a combination of advanced animal healthcare infrastructure and a widespread focus on livestock productivity has driven significant demand for high efficacy and cutting-edge parasiticide solutions. Stakeholders in this region continue to invest in research programs and adopt regulatory practices that encourage innovation and improved animal welfare standards.
In the combined region of Europe, Middle East, and Africa, regulatory landscapes are evolving to meet the twin objectives of market competitiveness and environmental sustainability. Here, premium quality products that are aligned with stringent safety norms offer considerable growth potential. Awareness about zoonotic diseases and the role of parasitic control in ensuring food security is also catalyzing product enhancements and strategic partnerships.
The Asia-Pacific region, on the other hand, presents unique challenges and opportunities driven by rapid urbanization, a rising pet ownership trend, and the dominance of agriculture-based economies. This region is characterized by robust demand for both conventional treatments and emerging advanced parasiticide formulations, driven by improved distribution networks and an increasingly informed consumer base. Overall, these regional insights call for a strategic approach that embraces local market dynamics while leveraging global best practices to secure a competitive edge.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Key Companies Shaping the Veterinary Parasiticides Industry
The market is notably influenced by a host of key companies that are setting benchmarks in innovation and quality. Industry leaders such as AB Vista Inc. and Alltech Inc. have firmly established their presence by investing in robust research and development platforms that consistently deliver high-performing products. Companies like Ashish Life Science Pvt Limited and Aurora Pharmaceutical, Inc. continue to push the envelope with novel formulations, ensuring competitive advantage through advanced applications of biotechnology.
Established giants such as Bayer AG and Merck & Co., Inc. bring decades of expertise and a global operational footprint, which have continuously contributed to shaping market trends and setting rigorous quality standards. The contributions of firms like Bimeda Inc., Bioiberica, S.A., and Boehringer Ingelheim International GmbH have been vital in offering integrated therapeutic solutions designed for both companion animals and livestock.
Other notable entities including Cargill Inc., Ceva Sante Animale, and Covetrus Inc. have intensified market competitiveness by tailoring their portfolios to meet diverse regional and demographic requirements. Companies such as Dechra Pharmaceuticals Plc, Elanco Animal Health Incorporated, and Indian Immunologicals Limited continue to define industry benchmarks through their relentless pursuit of efficacy in parasiticides. Additionally, mid-sized firms like Jurox Animal Health Ltd., Neogen Corporation, and Norbrook Laboratories Ltd. have emerged as key players in specialized niches. Firms including PetIQ, LLC, Vetaid Animal Health, VetGuard Inc., along with Vetoquinol S.A. and Vetsafe Ltd., further complement the industry fabric, creating an ecosystem that fosters innovation, reliability, and strategic growth. Finally, as Virbac Corporation, Zhejiang Hisun Pharmaceutical Co., Ltd., and Zoetis Inc. drive forward globalization and advanced application methods, their influence remains a testament to the market's dynamic evolution.
The report delves into recent significant developments in the Veterinary Parasiticides Market, highlighting leading vendors and their innovative profiles. These include AB Vista Inc., Alltech Inc., Ashish Life Science Pvt Limited, Aurora Pharmaceutical, Inc., Bayer AG, Bimeda Inc., Bioiberica, S.A., Boehringer Ingelheim International GmbH, Cargill Inc., Ceva Sante Animale, Covetrus Inc., Dechra Pharmaceuticals Plc, Elanco Animal Health Incorporated, Indian Immunologicals Limited, Jurox Animal Health Ltd., Merck & Co., Inc., Neogen Corporation, Norbrook Laboratories Ltd., PetIQ, LLC, Vetaid Animal Health, VetGuard Inc., Vetoquinol S.A., Vetsafe Ltd., Virbac Corporation, Zhejiang Hisun Pharmaceutical Co., Ltd., and Zoetis Inc.. Actionable Recommendations for Market Leaders
For industry leaders navigating the evolving veterinary parasiticides landscape, a multi-pronged strategic approach is essential to capture emerging opportunities while mitigating potential risks. It is advisable for decision-makers to ramp up investment in research and development in order to foster product innovation. Developing more targeted parasiticide solutions that address specific parasitic challenges can aid in maintaining a competitive edge.
Leaders should also consider forming strategic collaborations and partnerships that bridge research institutions and technology providers, thereby enhancing the efficacy and safety of newer therapeutic compounds. Embracing digital transformation to optimize supply chain operations and improve customer engagement further consolidates market position. In an era where precision medicine and individualized treatment plans are becoming the norm, leveraging data analytics to better understand customer behaviors and regional demand will be vital.
Furthermore, it is imperative for companies to remain agile in response to evolving regulatory standards by implementing robust compliance frameworks. Proactive investment in staff training and in the development of digital tools for monitoring product performance and safety will help ensure that companies remain at the forefront of the market. Ultimately, by aligning innovative product development with robust operational strategies and strategic regional positioning, market leaders can unlock sustained growth and improved therapeutic outcomes across the veterinary parasiticides arena.
Conclusion: Strategic Outlook and Future Directions
In summary, the veterinary parasiticides market is marked by a dynamic interplay of innovation, regulatory evolution, and diverse consumer needs. The in-depth examination of various segmentation dimensions reveals a complex but highly promising environment where targeted product development and technological integration play crucial roles. Regions across the globe, from the Americas to Asia-Pacific, exhibit unique market dynamics that necessitate tailored strategies to maximize therapeutic efficacy and commercial success.
Key companies continue to set high standards in research and application, driving the market toward more refined and efficient parasiticide solutions. As industry trends shift towards precision medicine and digital integration, stakeholders must be prepared to adapt quickly and proactively. The market's future will be shaped by the continued evolution of regulatory landscapes and the successful integration of advanced technologies in both product development and distribution. Leading industry participants are, therefore, encouraged to adopt a forward-thinking mindset, recognizing that innovation and collaboration are the cornerstones for sustainable growth in this competitive sector.